Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Alosaimy

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
BMC Infectious Diseases|December 30, 2025
Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysisSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Microbiology Spectrum|August 26, 2025
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomesAshlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Microbiology Spectrum|March 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving EnterobacteralesSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2023
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomesAmer El Ghali, Taylor Morrisette, Sara Alosaimy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-TazobactamSara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, et al.
Microbiology Spectrum|November 29, 2023
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
BMC Infectious Diseases|December 30, 2025
Clinical efficacy and safety of eravacycline for the treatment of enterococcal infections: a subpopulation analysisSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Microbiology Spectrum|August 26, 2025
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomesAshlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Microbiology Spectrum|March 23, 2026
Real-world use of eravacycline for the treatment of mono- and polymicrobial infections involving EnterobacteralesSean R Van Helden, Ashlan J Kunz Coyne, Sara Alosaimy, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2023
Long-term evaluation of clinical success and safety of omadacycline in nontuberculous mycobacteria infections: a retrospective, multicenter cohort of real-world health outcomesAmer El Ghali, Taylor Morrisette, Sara Alosaimy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-TazobactamSara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, et al.
Microbiology Spectrum|November 29, 2023
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, et al.
Pageof 4